Stock comparison
Boston Scientific
United Therapeutics
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
BSX
Boston Scientific
Market cap
$85.88B
Sector
Healthcare
UTHR
United Therapeutics
Market cap
$24.13B
Sector
Healthcare
Overall winner
United Therapeutics UTHR
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | BSX | UTHR | Winner |
|---|---|---|---|
| Warren Buffett | 63C | 71B | UTHR |
| Benjamin Graham | 69B | 76B | UTHR |
| Philip Fisher |
Side-by-side metrics
| Metric | BSX | UTHR |
|---|---|---|
| Market cap | $85.88B | $24.13B |
| P/E (TTM) | 22.0x | 19.2x |
| EV/EBIT | 22.1x | 15.2x |
| ROIC (TTM) | 9.9% | 18.81% |
| Gross margin | 70.41% | 86.58% |
| Net margin | 17.24% | 40.61% |
| Revenue CAGR 5y | 13.99% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BSX leads on
- Market cap$85.88Bvs $24.13B+72%
UTHR leads on
- Debt / Equity-vs 0.4x+100%
- Net margin40.61%vs 17.24%+58%
More like UTHR
Related on invest-like
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.